The APAC blood transfusion diagnostics market is expected to grow from US$ 875.20 million in 2022 to US$ 1,380.34 million by 2028. It is estimated to grow at a CAGR of 7.9% from 2022 to 2028.

Elevated Healthcare Expenditure in Emerging Economies to Boost Market in Coming Years

Healthcare budget allocations help countries strengthen workforces and improve this sector’s productivity, thereby contributing to economic performance. Rapid economic developments allow developing countries to raise their healthcare expenditures, enabling them to establish better medical service infrastructure by leveraging technological advancements. The Government of India, through its National Health Authority agency, implemented Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in 2019. This scheme has facilitated free/affordable treatment for cancer patients in the country. As per the data published by the National Health Authority of India, ~470,133 cancer cases were treated under AB-PMJAY in 2019. Such initiatives are likely to provide lucrative opportunities for companies in the blood transfusion diagnostics market to introduce advanced technologies for the blood transfusion diagnostics market in Asia Pacific.

Market Overview

China dominated the blood transfusion diagnostics market in Asia Pacific in 2022. The market growth in China is attributed to the increased use of advanced technologies in blood-related diagnoses, followed by a surge in the number of blood donation camps and blood banks in the country. The nation has a blood donation law in place that allows voluntary unpaid blood donation, and the donated blood can only be used for clinical practice. China’s National Health Commission recorded 15.53 million blood donations in 2020, despite the pandemic-related restrictions. This figure is 40-times more than that recorded in 1998. According to Xinhua news, from January to April 2021, 5.12 million blood donations were registered nationwide. Therefore, the increasing number of blood donations for clinical use leads to high demand for blood transfusion diagnostics to screen the blood groups.

APAC Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

APAC Blood Transfusion Diagnostics Market Segmentation

The APAC blood transfusion diagnostics market is segmented based on product, application, end user, and country.

Based on product, the APAC blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. The instruments & kits segment held the larger market share in 2022. Based on application, the APAC blood transfusion diagnostics market is bifurcated into blood grouping and disease screening. The disease screening segment held the larger market share in 2022. Based on end user, the APAC blood transfusion diagnostics market is segmented into hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks segment dominated the market in 2022. Based on country, the APAC blood transfusion diagnostics market has been categorized into China, India, Japan, South Korea, Australia, and Rest of APAC. Our regional analysis states that China dominated the market in 2022.

Abbott; BAG Diagnostics GmbH; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; Grifols, S.A.; Immucor, Inc.; Ortho Clinical Diagnostics (QuidelOrtho Corporation); Quotient Limited; and Thermo Fisher Scientific Inc. are the leading companies operating in the APAC blood transfusion diagnostics market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Blood Transfusion Diagnostics Market – By Product
1.3.2 APAC Blood Transfusion Diagnostics Market – By Application
1.3.3 APAC Blood Transfusion Diagnostics Market – By End User
1.3.4 APAC Blood Transfusion Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Blood Transfusion Diagnostics Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Blood Transfusion Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rapid Increase in Chronic Diseases
5.1.2 Need for Blood Transfusion due to Rise in Organ Transplants Surgeries
5.2 Market Restraints
5.2.1 Problems Associated with Blood Transfusion Services
5.3 Market Opportunities
5.3.1 Elevated Healthcare Expenditure in Emerging Economies
5.4 Future Trends
5.4.1 Technological Developments in Blood Transfusion Diagnostics
5.5 Impact Analysis
6. Blood Transfusion Diagnostics Market– APAC Analysis
6.1 APAC Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
7. APAC Blood Transfusion Diagnostics Market Analysis – By Product
7.1 Overview
7.2 APAC Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
7.3 Instruments and Kits
7.3.1 Overview
7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8. APAC Blood Transfusion Diagnostics Market Analysis – By Application
8.1 Overview
8.2 APAC Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
8.3 Disease Screening
8.3.1 Overview
8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8.4 Blood Grouping
8.4.1 Overview
8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9. APAC Blood Transfusion Diagnostics Market Analysis – By End User
9.1 Overview
9.2 APAC Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)
9.3 Blood Banks
9.3.1 Overview
9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.6 Plasma Fractionation Companies
9.6.1 Overview
9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
10. APAC Blood Transfusion Diagnostics Market Analysis – Country Analysis
10.1 Overview
10.1.2 APAC: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.3 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.2.1.4 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.1.5 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.3 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.2.2.4 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.2.5 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.2.3 India Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.3.3 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.2.3.4 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.3.5 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.2.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.4.3 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.2.4.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.4.5 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.2.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.5.3 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.2.5.4 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.5.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.2.6 Rest of APAC: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of APAC: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.2.6.4 Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.6.5 Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Grifols, S.A.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Immucor, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DiaSorin S.p.A.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Quotient Limited
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BAG Diagnostics GmbH
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Mn)
Table 2. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 3. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 4. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 5. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 6. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 7. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 8. India: National Estimation of Blood Requirement in India (2018)
Table 9. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 10. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 11. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 12. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 13. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 14. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 15. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 16. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 17. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 18. Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 19. Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 20. Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 21. Recent Inorganic Growth Strategies
Table 22. Recent Organic Growth Strategies
Table 23. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Blood Transfusion Diagnostics Market Segmentation
Figure 2. APAC Blood Transfusion Diagnostics Market – By Country
Figure 3. APAC Blood Transfusion Diagnostics Market Overview
Figure 4. APAC Blood Transfusion Diagnostics Market, By Product
Figure 5. APAC Blood Transfusion Diagnostics Market, By Country
Figure 6. APAC: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis: APAC Blood Transfusion Diagnostics Market
Figure 9. APAC Blood Transfusion Diagnostics Market– Revenue Forecast and Analysis
Figure 10. APAC Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
Figure 11. APAC Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 12. APAC Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 13. APAC Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
Figure 14. APAC Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 15. APAC Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 16. APAC Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028 (%)
Figure 17. APAC Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 19. APAC Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 20. APAC Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Blood Transfusion Diagnostics Market Overview, by Country (2021)
Figure 22. APAC: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 23. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Rest of APAC: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC blood transfusion diagnostics market.
● Highlights key business priorities to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the APAC blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the blood transfusion diagnostics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Asia-Pacific Blood Transfusion Diagnostics Market

● Abbott
● BAG Diagnostics GmbH
● Bio-Rad Laboratories, Inc.
● DiaSorin S.p.A.
● F. Hoffmann-La Roche Ltd      
● Grifols, S.A.
● Immucor, Inc.  
● Ortho Clinical Diagnostics (QuidelOrtho Corporation)
● Quotient Limited
● Thermo Fisher Scientific Inc.